HES1 and gastric cancer: In gastric cancer, simultaneous blockade of Notch (using DAPT) and PI3K/Akt signaling (using LY294002) can synergistically inhibit the expression of Notch1, Hes1, and p-Akt, significantly suppressing tumor metastasis (193).